Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Journal of Medicinal Chemistry|February 1, 1987
The mechanism of activation of 4-hydroxycyclophosphamideR F Borch, J A MillardJournal of Leukocyte Biology|April 1, 1987
Low-dose X-irradiation and 4-hydroperoxycyclophosphamide distinguishes three Lyt-1+ lymph node T-cell subtypes that respond to specific antigen in vitroC Clark, I LaSota, R F BorchJournal of Medicinal Chemistry|November 7, 2000
Activation mechanisms of nucleoside phosphoramidate prodrugsC L Freel Meyers, R F BorchJournal of Leukocyte Biology|February 1, 1985
Evidence that X-irradiation and 4-hydroperoxycyclophosphamide affects different lymphocytes that respond to specific antigen in vitroC Clark, I LaSota, R F BorchJournal of Medicinal Chemistry|August 24, 2000
Development of novel quinone phosphorodiamidate prodrugs targeted to DT-diaphoraseC Flader, J Liu, R F BorchJournal of Medicinal Chemistry|July 7, 1995
Synthesis and biological evaluation of 5-fluoro-2'-deoxyuridine phosphoramidate analogsK M Fries, C Joswig, R F BorchCancer Research|October 15, 1988
Diethyldithiocarbamate inhibition of murine bone marrow toxicity caused by cis-diamminedichloroplatinum(II) or diammine-(1,1-cyclobutanedicarboxylato)platinum(II)A Gringeri, P C Keng, R F BorchBlood|September 1, 1992
Diethyldithiocarbamate induction of cytokine release in human long-term bone marrow culturesC J East, C N Abboud, R F BorchCancer Research|March 1, 1982
Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysisJ E Low, R F Borch, N E SladekJournal of Medicinal Chemistry|April 1, 1984
In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solutionR F Borch, T R Hoye, T A SwansonPageof 5